Add like
Add dislike
Add to saved papers

Antibodies to M-type phospholipase A2 receptor (PLA 2 R) in membranous lupus nephritis.

Lupus 2019 March
BACKGROUND: Antibodies to M-type phospholipase A2 receptor (a-PLA2 R) have been identified in most patients with idiopathic membranous nephropathy, but the prevalence in membranous lupus nephritis (MLN) is still unclear. The objective of this study was to assess the prevalence of a-PLA2 R antibodies in a large cohort of patients with lupus nephritis.

METHODS: a-PLA2 R antibodies were measured by ELISA in serum from patients with systemic lupus erythematosus ( n = 190), of whom 37 had a biopsy-proven MLN. Positive samples were confirmed by commercial ELISA kit, Western blot and immunohistochemistry in renal tissue.

RESULTS: A total of 10 from 190 patients (5.3%) with systemic lupus erythematosus had circulating a-PLA2 R measured by in-house ELISA assay. The antibodies were detected in 7 patients with MLN (18.9%) and 3 patients with non-renal lupus disease (3.2%). PLA2 R staining was detected in the kidney biopsy of 5 of the 7 (71.4%) patients with MLN. a-PLA2 R levels were associated with active disease but not proteinuria levels. Presence of a-PLA2 R antibodies at baseline was associated with worse remission rates and longer time to remission compared to those patients serologically negative.

CONCLUSIONS: a-PLA2 R antibodies can be detected with low prevalence in MLN patients, but their detection is associated with a worse renal prognosis.

Full text links

We have located links that may give you full text access.
Can't access the paper?
Try logging in through your university/institutional subscription. For a smoother one-click institutional access experience, please use our mobile app.

For the best experience, use the Read mobile app

Mobile app image

Get seemless 1-tap access through your institution/university

For the best experience, use the Read mobile app

All material on this website is protected by copyright, Copyright © 1994-2024 by WebMD LLC.
This website also contains material copyrighted by 3rd parties.

By using this service, you agree to our terms of use and privacy policy.

Your Privacy Choices Toggle icon

You can now claim free CME credits for this literature searchClaim now

Get seemless 1-tap access through your institution/university

For the best experience, use the Read mobile app